EP4665344A1 — Lumateperone and derivatives thereof for modulating the nervous system
Assigned to Intra Cellular Therapies Inc · Expires 2025-12-24 · 0y expired
What this patent protects
The present disclosure relates to use of Compounds of Formula (I), Compounds of Formula (II), and related analogs, for enhancing neuritogenesis, enhancing neurite outgrowth, enhancing neural growth, neural connectivity, synaptic density, dendritic spine density, dendritic spine s…
USPTO Abstract
The present disclosure relates to use of Compounds of Formula (I), Compounds of Formula (II), and related analogs, for enhancing neuritogenesis, enhancing neurite outgrowth, enhancing neural growth, neural connectivity, synaptic density, dendritic spine density, dendritic spine size, and excitatory neurotransmission, in the brain (e.g., in the medial prefrontal cortex), and other methods and uses related thereto.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.